• Successful Year for Uniqsis

News & Views

Successful Year for Uniqsis

Cambridge-based Uniqsis reported significant first year developments culminating with the first of its FlowSynâ„¢ Continuous Flow Reactor systems installed in pharmaceutical development laboratories.
Managing Director Martyn Fordham said “It’s been an incredibly busy but rewarding year. The development team took FlowSyn from concept design and first prototype phases through to beta trial systems for pilot customers and now to the manufacture of fully standards-tested production models, and all in less than 12 months.” Dr Mark Ladlow, a leading authority on flow chemistry has also joined the company as Chief Scientific Officer.
Mark was until recently head of the GSK Cambridge Technology Laboratory based within the University of Cambridge. New distributors for FlowSyn have been appointed in France, USA, Italy and India.

Digital Edition

Lab Asia 31.6 Dec 2024

December 2024

Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...

View all digital editions

Events

Smart Factory Expo 2025

Jan 22 2025 Tokyo, Japan

Instrumentation Live

Jan 22 2025 Birmingham, UK

SLAS 2025

Jan 25 2025 San Diego, CA, USA

Arab Health

Jan 27 2025 Dubai, UAE

Nano Tech 2025

Jan 29 2025 Tokyo, Japan

View all events